ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"

Nov.12.2024
ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"
ISMOD launches new HTP products in the US market, available on brand's website and vapesourcing, catering to e-cigarette users.

Special Disclaimer:

  • This article is for industry communication purposes only and does not endorse any brand or product.
  • The images displayed in this article are for factual description only and are not advertisements for any product.
  • This article is restricted to minors.

 

Recently, 2Firsts noticed that the heated tobacco brand ISMOD has launched two new HTP products in the US market—the ISMOD Mini Tobacco Heating Device and the ISMOD Jet Tobacco Heating Device. These products are now available on the ISMOD official website and the US e-cigarette distributor site, Vapesourcing.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini | Image source: ISMOD official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Jet | Image source: ISMOD official website

 

 Specifically, the product features of the ISMOD Mini and ISMOD Jet are as follows:

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Product specifications of ISMOD Mini and ISMOD Jet | Illustration: 2Firsts

 

According to the distributor website Vapesourcing, the ISMOD Mini is described as the "lightest HNB device in the world."

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini is the "lightest HNB device in the world" | Image source: vapesourcing

 

In addition, both the ISMOD Mini and ISMOD Jet are marked as "best used with BUDDZ tobacco sticks." The BUDDZ official website also features a heated tobacco device, the BUDDZ DEVICE, which closely resembles the ISMOD Mini in terms of design and specifications.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: BUDDZ DEVICE | Image source: BUDDZ official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation into English: BUDDZ DEVICE|Image source: BUDDZ official website.

 

As early as the tobacco exhibition held in Dortmund this September, 2Firsts had already noticed the ISMOD brand and its products. The ISMOD II PLUS, in particular, became the brand's main highlight at the exhibition, featuring a battery device combined with two tobacco stick heating devices.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: Dortmund Tobacco Exhibition ISMOD Booth | Image Source: 2Firsts

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD II PLUS | Image Source: ISMOD

 

It is worth noting that the ISMOD Mini and ISMOD Jet were previously only available on the official ISMOD websites for regions such as Europe, the UK, and Jordan. Their launch on the US e-cigarette distributor site Vapesourcing makes them the only two HTP products currently listed on the site.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Heating tobacco devices displayed on the vapesourcing website | Image source: vapesourcing

 

The ISMOD official website shows that the brand is owned by ISMOD UK Ltd., a registered company in England and Wales with registration number 13047166. The company's registered address is in the Westminster district of the UK, and its business address is on Greenlands Avenue in London.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Company information displayed on the ISMOD brand official website | Image source: ISMOD official website

 

2Firsts will continue to monitor the latest products and market trends in the heated tobacco sector, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14